Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Director comp.
|
|
Evelo Biosciences, Inc. (EVLO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 1,996 shares
@ $3.94, valued at
$7.9k
Granted 60,000 restricted stock units
@ $0
Exercised 15,000 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 3,128 shares
@ $9.51, valued at
$29.7k
Exercised 6,625 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 342 shares
@ $9.51, valued at
$3.3k
Exercised 1,171 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 3,434 shares
@ $9.51, valued at
$32.7k
Exercised 6,500 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 2,004 shares
@ $9.51, valued at
$19.1k
Exercised 6,500 restricted stock units
@ $0 |
|
| 07/13/2023 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 3,246,753 shares
@ $2.31, valued at
$7.5M
|
|
| 07/12/2023 |
4
| Reynolds Alexander C (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 2,000 options to buy
@ $3.38, valued at
$6.8k
|
|
| 07/12/2023 |
4
| Moore Jeffrey R. (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 2,000 options to buy
@ $3.38, valued at
$6.8k
|
|
| 06/12/2023 |
4
| Williams Tonya (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| Hohneker John (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| McHugh Julie (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| McInnes Iain B. (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| MELAS KYRIAZI THEO (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| Andres Juan (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 06/12/2023 |
4
| Rosiello Robert L. (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.11, valued at
$3.3k
|
|
| 06/12/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.97, valued at
$970k
|
|
| 06/12/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 22,571 shares
@ $0.1418, valued at
$3.2k
|
|
| 05/10/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 66,730 shares
@ $0.1255, valued at
$8.4k
|
|
| 05/10/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 68,014 shares
@ $0.1255, valued at
$8.5k
|
|
| 05/10/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 38,531 shares
@ $0.1255, valued at
$4.8k
|
|
| 05/10/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 3,537 shares
@ $0.1255, valued at
$443.9 |
|
| 05/09/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 130,000 restricted stock units
@ $0 |
|
| 05/09/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 23,437 restricted stock units
@ $0 |
|
| 05/09/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 132,500 restricted stock units
@ $0 |
|
| 05/09/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 130,000 restricted stock units
@ $0 |
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 1,125,000 options to buy
@ $0.97, valued at
$1.1M
Granted 375,000 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 530,000 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 520,000 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 520,000 restricted stock units
@ $0 |
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| CARRIERE STEPHEN J (Principal Accounting Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 151 shares
@ $1.0604, valued at
$160.1
Exercised 354 restricted stock units
@ $0 |
|
| 10/14/2022 |
4
| Char Daniel (General Counsel) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.24, valued at
$89.6k
|
|
|
|
|